| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.006 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |